{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-22",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "discontinued_date": "10/16/2026",
      "update_type": "New",
      "initial_posting_date": "10/16/2026",
      "package_ndc": "0054-0652-25",
      "generic_name": "Vigabatrin Tablet",
      "contact_info": "800-631-2174",
      "related_info": "The decision to discontinue this drug product was due to a business decision and not due to any reasons of safety or effectiveness.",
      "openfda": {
        "application_number": [
          "ANDA213104"
        ],
        "brand_name": [
          "VIGABATRIN"
        ],
        "generic_name": [
          "VIGABATRIN"
        ],
        "manufacturer_name": [
          "Hikma Pharmaceuticals USA Inc"
        ],
        "product_ndc": [
          "0054-0652"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "VIGABATRIN"
        ],
        "rxcui": [
          "199521"
        ],
        "spl_id": [
          "f575e137-5300-4e13-a40e-5573f6c8a066"
        ],
        "spl_set_id": [
          "5ed8d293-b7d8-4c66-9c31-8075e6f99092"
        ],
        "package_ndc": [
          "0054-0652-25"
        ],
        "nui": [
          "N0000175753"
        ],
        "pharm_class_epc": [
          "Anti-epileptic Agent [EPC]"
        ],
        "unii": [
          "GR120KRT6K"
        ]
      },
      "update_date": "10/16/2026",
      "therapeutic_category": [
        "Neurology"
      ],
      "dosage_form": "Tablet",
      "presentation": "Vigabatrin, Tablet, 500 mg (NDC 0054-0652-25)",
      "company_name": "Hikma Pharmaceuticals USA, Inc.",
      "status": "To Be Discontinued"
    }
  ]
}